Caballero Velázquez, T., Sánchez-Abarca, L. I., Gutiérrez-Cosío, S., Blanco, B., Calderón, C., Herrero, C., . . . Pérez Simón, J. A. (2012). The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation.
Citación estilo ChicagoCaballero Velázquez, Teresa, et al. The Novel Combination of Sirolimus and Bortezomib Prevents Graft-versus-host Disease but Maintains the Graft-versus-leukemia Effect After Allogeneic Transplantation. 2012.
Cita MLACaballero Velázquez, Teresa, et al. The Novel Combination of Sirolimus and Bortezomib Prevents Graft-versus-host Disease but Maintains the Graft-versus-leukemia Effect After Allogeneic Transplantation. 2012.